Rituximab - Rituxan; IDEC-C2B8; MabThera; CD20 monoclonal antibody, recombinant -- Product Record

CD20 Mab, rDNA

    Nomenclature:
      CD20 Mab, rDNA [BIO]
      Rituxan [TR]
      Rituximab [FDA USAN INN]
      anti-(human CD20 antigen) immunoglobulin G1 (human-mouse monoclonal IDEC-C2B8 gamma1-chain) disulfide with human-mouse mono-clonal IDEC-C2B8 gamma-chain, dimer [CAS]
      immunoglobulin G 1 (human-mouse monoclonal IDEC-C2B8 gamma1-chain anti-human antigen CD 20), disulfide with human-mouse monoclonal IDEC-C2B8 kappa-chain, dimer [CAS]
      174722-31-7 [CAS RN]
      anti-CD20 monoclonal antibody [SY]
      CD20 monoclonal antibody, recombinant [SY]
      IDEC-C2B8 [SY]
      pan-B antibodies [SY]
      MabThera [TR used by Roche outside of U.S. and Japan]

    molecular weight (kDa) = 144.6

    FDA Class:  Biologic BLA

    Year of approval (FDA) = 1997